Healthcare sector | Medical Devices industry
| Price | $11.65 |
|---|---|
| Shares Outstanding | 40.14M |
| All-Time Low | $5.62 |
| 52-Week Low | $10.24 |
| Net Cash / Share | $0 |
|---|---|
| Net Current Assets / Share | $0.4 |
| Net Tangible Assets / Share | $4.54 |
| Shares Outstanding Ave Change (Annual) | 24.72% |
| Shares Δ YoY | 3.55% |
| Avg CA Burn (Annual %) | 20.76% (as of 3-8-2026) |
| Avg CA Burn (Quarterly %) | -0.80% (as of 3-8-2026) |
| Max Earning Power / Share | $4.08 |
|---|---|
| Adjusted Earning Power |
$-0.53
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
|
| Non-Cash Charges to Market Cap |
3.2%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
|
| Avg EBITDA (5Y) | 9.3M (as of 3-8-2026) |
| Avg EBITDA (5Q) | 7.5M (as of 3-8-2026) |
| Avg Net Income (5Y) | -83.9M (as of 3-8-2026) |
| Avg Net Income (5Q) | -24.3M (as of 3-8-2026) |
| Dividend indicators | Value | Date |
|---|---|---|
| Current Dividend Streak | No | 3-8-2026 |
| Consecutive Years Paid | No | 3-8-2026 |
| Pays Dividend | No | 3-8-2026 |
| Income indicators | Value | Date |
|---|---|---|
| EBITDA Positive | Yes | 3-8-2026 |
| Net Income Positive | No | 3-8-2026 |
| Current Dividend Streak | No | 3-8-2026 |
Pick a metric to view its history table and chart.
Formula: Tangible Book Value / shares from balance statements. Includes 6 quarterly + 4 annual.
Chart plots one TBV / Share point per report date (duplicate same-date annual/quarterly rows are merged).
| Report Date | Period | TBV / Share | Tangible Book Value | Shares Used |
|---|---|---|---|---|
| 2025-12-31 | Quarterly | $4.58 | 182.3M ($182,338,000) | 39.8M (39,834,000) |
| 2025-09-30 | Quarterly | $4.35 | 171.9M ($171,911,000) | 39.5M (39,519,000) |
| 2025-06-30 | Quarterly | $4.67 | 184.5M ($184,545,000) | 39.5M (39,483,000) |
| 2025-03-31 | Quarterly | $4.66 | 182.1M ($182,147,000) | 39.1M (39,096,000) |
| 2024-12-31 | Quarterly | $5.44 | 209.4M ($209,387,000) | 38.5M (38,486,000) |
| 2024-12-31 | Annual | $5.44 | 209.4M ($209,387,000) | 38.5M (38,486,000) |
| 2024-09-30 | Quarterly | $5.93 | 226.4M ($226,444,000) | 38.2M (38,209,000) |
| 2023-12-31 | Annual | $7.70 | 286.3M ($286,306,000) | 37.2M (37,165,000) |
| 2022-12-31 | Annual | $10.82 | 218.2M ($218,155,000) | 20.2M (20,162,000) |
| 2021-12-31 | Annual | $10.74 | 213M ($212,951,000) | 19.8M (19,836,937) |
Revenue from income statements. Includes 4 annual.
Chart plots one annual Revenue point per report date.
| Report Date | Revenue |
|---|---|
| 2024-12-31 | 799.5M ($799,491,000) |
| 2023-12-31 | 746.6M ($746,641,000) |
| 2022-12-31 | 460.7M ($460,713,000) |
| 2021-12-31 | 464.5M ($464,479,000) |
Historical cash dividends per share from Yahoo ex-dividend dates.
| Date | Dividend / Share |
|---|---|
| No dividend payment history available yet | |
| Date | Shares Outstanding | Delta |
|---|---|---|
| 2026-03-04 | 40,144,397 | +544,738 |
| 2025-11-05 | 39,599,659 | +105,394 |
| 2025-09-17 | 39,494,265 | -35 |
| 2025-08-06 | 39,494,300 | +313,500 |
Latest short-interest change: 1,100,792 shares (2.77% of float) | Days to cover: 4.09
| Date | Short Interest | Delta | Δ % |
|---|---|---|---|
| 2026-03-12 | 1,100,792 shares | +50,665 | +4.82% |
| 2026-02-27 | 1,050,127 shares | +42,388 | +4.21% |
| 2026-02-11 | 1,007,739 shares | -58,963 | -5.53% |
Volume/ratio use shares outstanding as of the event date (frozen).
| Date | Volume | Shares Outstanding | Volume / Shares | Price |
|---|---|---|---|---|
| No interesting volume events | ||||
Orthofix Medical Inc. operates as a medical technology company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulation devices that enhance bone fusion, including adjunctive and noninvasive treatment of the cervical and lumbar spine, as well as a therapeutic treatment for non-spinal, appendicular fractures, and fresh fractures that have not healed; designs, develops, and markets a portfolio of spine fixation and motion preservation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and provides 7D flash navigation system for spine and cranial procedures. Its Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.